Beckley Psytech Ltd, the private, clinical-stage biopharmaceutical company dedicated to improving the lives of people living with neuropsychiatric disorders by developing effective and rapid-acting psychedelic medicines, today announced the publication of a new paper in The Journal of Psychopharmacology which demonstrates the safety, tolerability and rapid-acting subjective effects of BPL-003, Beckley Psytech’s novel, synthetic, intranasal benzoate salt formulation of 5-MeO-DMT (also known as mebufotenin).
Read morePsychological Flexibility and Psychedelics
In a new study, researchers found that psychological flexibility, several facets of mindfulness, and values-congruent living significantly improved following psilocybin and were maintained through week 16.
Additionally, improvements in psychological flexibility and experiential acceptance were strongly associated with reductions in depression severity following psilocybin.
Keep reading for the full article at Nature.com
Read moreCreating a Psilocybin Session Playlist
Psychedelic music session playlists have been utilized consistently for modern psychedelic-assisted therapy clinical trials, and more recently researchers at Johns Hopkins University and Imperial College of London have specifically studied the effect of these music playlists on participants in trials.
Read moreMeasuring the Potency of Mushrooms
Big news- a collaborative effort among scientists from the University of Texas at Arlington, Scottsdale Research Institute in Phoenix, Shimadzu Scientific Instruments in Maryland, and Millipore-Sigma in Round Rock, Texas, has led to the development of a new method for quantifying the potency of psilocybin and psilocin.
Read morePsychedelics and Self Perception
Psychedelics can help dissolve the individual ego, an outcome sought in many spiritual traditions.
This dissolution fosters the understanding that one is not an isolated entity but part of a larger system.
Read moreLSD for Anxiety?
The government finally fast-tracked LSD as an anxiety treatment.
MindMed, the first publicly traded pharmaceutical company focused on psychedelics, said its drug has received a breakthrough designation from the FDA.
Read moreMore on HPPD
Here’s another look at HPPD, Hallucinogenic persistent perception disorder.
There are two types of HPPD: type 1 is characterised by brief "flashbacks", and type 2 sufferers experience chronic symptoms that can last months or a lifetime.
Read morePsychedelics and Ethics
Psychedelics and Recreational Use
This article looks at whether psychedelics are safe enough for recreational use.
Read moreMicrodosing
Psychedelics for Soldiers with Trauma
Research suggests that the psychedelic drug MDMA, an empathogenic stimulant also known as Molly or ecstasy, can spark changes in the brain that induce a childlike state of neuroplasticity and help forge new neural connections.
(It could well be approved for PTSD by the U.S. Food and Drugs Administration in August after two advanced stage trials showed significant benefits.)
Researchers are also studying other psychedelics as well, like the powerful drug ibogaine.
Read more